Sittner & Nelson’s Twist Bioscience TWST Stock Holding History

Sittner & Nelson’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-200	Closed	-$4.76K	–	496
2022 Q4	$4.76K	Hold	200	–	–	﹤0.01%	388
2022 Q3	$7K	Hold	200	–	–	﹤0.01%	362
2022 Q2	$7K	Hold	200	–	–	﹤0.01%	397
2022 Q1	$10K	Hold	200	–	–	0.01%	346
2021 Q4	$15K	Sell	200 -75	-27%	-$7.7K	0.01%	306
2021 Q3	$29K	Hold	275	–	–	0.02%	229
2021 Q2	$37K	Buy	275 +200	+267%	+$23.3K	0.03%	199
2021 Q1	$9K	Buy	+75	New	+$11.4K	0.01%	301

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Sittner & Nelson's TWST Position: Q1 2023 in Review

Sittner & Nelson sold out of Twist Bioscience (TWST) in Q1 2023, closing a stake of 200 shares — an estimated $4.76K sold.

Sittner & Nelson first reported a position in TWST in Q1 2021 and held it in 8 quarters. The position peaked at $37K in Q2 2021. 201 funds tracked by Wall St. Rank hold TWST as of Q1 2023.

Sittner & Nelson reported no remaining Twist Bioscience position as of Q1 2023 after selling out during the quarter.
Sittner & Nelson sold 200 Twist Bioscience shares in Q1 2023, an estimated $4.76K.
Sittner & Nelson first reported a position in Twist Bioscience in Q1 2021 and held it in 8 quarters.
Sittner & Nelson's Twist Bioscience position peaked at $37K in Q2 2021.
201 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2023.

Based on Sittner & Nelson's 13F filing for Q1 2023, filed 9 May 2023.